Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (211-220 of 240) with videos related to

Pageof 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 23, 2009
Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancersJ C Soria, C Massard, N Magné, et al.
British Journal of Cancer|October 3, 1999
A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neckC Couteau, N Chouaki, S Leyvraz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I studyG G Chabot, J P Armand, C Terret, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structureK Kirshenbaum, A E Barron, R A Goldsmith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinomaS Faivre, T Le Chevalier, C Monnerat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group studyJ H Schornagel, J Verweij, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastomaE Raymond, M Fabbro, V Boige, et al.
Journal of Environmental Radioactivity|September 19, 2008
Measurement and modelling of radioxenon plumes in the Ottawa ValleyT J Stocki, P Armand, Ph Heinrich, et al.
Optics Express|May 14, 2021
Small footprint phase locking system for a large tiled aperture laser arrayA Boju, G Maulion, J Saucourt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancerE Raymond, W W ten Bokkel Huinink, J Taïeb, et al.
Pageof 24

Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|June 23, 2009
Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancersJ C Soria, C Massard, N Magné, et al.
British Journal of Cancer|October 3, 1999
A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neckC Couteau, N Chouaki, S Leyvraz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I studyG G Chabot, J P Armand, C Terret, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structureK Kirshenbaum, A E Barron, R A Goldsmith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinomaS Faivre, T Le Chevalier, C Monnerat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group studyJ H Schornagel, J Verweij, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastomaE Raymond, M Fabbro, V Boige, et al.
Journal of Environmental Radioactivity|September 19, 2008
Measurement and modelling of radioxenon plumes in the Ottawa ValleyT J Stocki, P Armand, Ph Heinrich, et al.
Optics Express|May 14, 2021
Small footprint phase locking system for a large tiled aperture laser arrayA Boju, G Maulion, J Saucourt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancerE Raymond, W W ten Bokkel Huinink, J Taïeb, et al.
Pageof 24